Lexaria Bioscience (LEXX) EBIT Growth (3y) (2020 - 2026)
Lexaria Bioscience (LEXX) EBIT Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
-1,580.97% |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-29.67% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-50.81% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
16.35% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
13.47% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Lexaria Bioscience |
7.17 Mn |
1.65 Mn |
20,000.00 |
-3.13% |
| Date | Value |
|---|
| Feb 28, 2026 |
-3.13% |
| Nov 30, 2025 |
2.45% |
| Aug 31, 2025 |
-53.14% |
| May 31, 2025 |
-15.75% |
| Feb 28, 2025 |
-23.83% |
| Nov 30, 2024 |
-10.33% |
| Aug 31, 2024 |
-19.14% |
| May 31, 2024 |
12.10% |
| Feb 29, 2024 |
15.43% |
| Nov 30, 2023 |
-32.18% |
| Aug 31, 2023 |
-8.90% |
| May 31, 2023 |
-19.40% |
| Feb 28, 2023 |
-7.63% |
| Nov 30, 2022 |
-20.21% |
| Aug 31, 2022 |
12.46% |
| May 31, 2022 |
-26.74% |
| Feb 28, 2022 |
-7.90% |
| Nov 30, 2021 |
-41.89% |
| Aug 31, 2021 |
-2.01% |
| May 31, 2021 |
9.17% |
